CEO, 73Health Greater China

Health Technology Executive in Asia

Lasse Liukkonen

I lead the expansion of clinically advanced remote diagnostics across Mainland China, Hong Kong, and the Greater Bay Area. With nearly two decades of operational experience in China, my focus is on scaling digital healthcare infrastructure, aligning regulatory frameworks, and building long-term institutional partnerships in one of the world’s most dynamic healthcare markets.
Lasse Liukkonen

73Health

As CEO of 73Health Greater China, Lasse Liukkonen leads the regional expansion of clinically advanced remote diagnostics across Mainland China, Hong Kong, and the Greater Bay Area. The work focuses on practical healthcare infrastructure that combines structured clinical data, medical devices, and digital workflows to support high-quality remote examination. The role includes market development, institutional partnerships, localisation, and the operational scaling of digital healthcare solutions in one of the world’s most dynamic healthcare markets.

Strategic Focus

Digital Healthcare Infrastructure

Development and deployment of clinically structured remote diagnostic systems that enable high-quality examination outside traditional clinical environments.

Cross-Border Health Technology Expansion

Scaling health technology solutions from Europe into Asian markets through localisation, regulatory alignment, and long-term operational development across Mainland China and Hong Kong.

Institutional Partnerships in Greater China

Building long-term collaborations with healthcare providers, technology companies, and public sector organisations to support the adoption of structured remote diagnostics.

Insights

Perspectives on digital healthcare, remote diagnostics, and institutional collaboration across China and Asia.

Clinically structured remote examination can improve access to care, reduce unnecessary visits, and support more efficient healthcare workflows across large and complex markets.

Expanding health technology in Mainland China and Hong Kong requires practical localisation, regulatory alignment, and long-term institutional commitment.

Cross-border healthcare innovation succeeds when technology, market realities, and trusted partnerships are developed together over time.

Professional Contact

For professional enquiries, partnerships, speaking engagements, or collaboration opportunities, please use the form below or contact directly via email or LinkedIn.

Direct Contact

hello@lasseliukkonen.com

Related Websites